Transfusion Diagnostics--Strategic Assessments of Major Suppliers and Emerging Market Entrants
This new report from VPGMarketResearch.com provides extensive analyses of major current and emerging suppliers of transfusion diagnostic instruments and reagents. The assessments include: ul>li>Sales/li>li>Product portfolios/li>li>Marketing tactics/li>li>Technological know-how/li>li>New products in R&D/li>li>Collaborative arrangements/li>li>Business strategies/li>/ul>Contains 50 pages
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio Rad
CellMark Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Grifols
Hologic/GenProbe
Immucor
Ortho Clinical Diagnostic
Proteome Sciences
Quest
Quidel
Roche
Siemens
Tecan
ThermFisher/Life Technologies
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio Rad
CellMark Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Grifols
Hologic/GenProbe
Immucor
Ortho Clinical Diagnostic
Proteome Sciences
Quest
Quidel
Roche
Siemens
Tecan
ThermFisher/Life Technologies
More Publications
Hemostasis Diagnostics--Strategic Assessments of Major Suppliers and Emerging Market Entrants
US$ 2,000.00
July 2016
45 pages
Transfusion Diagnostics: Strategic Assessments of Current and Emerging Competitors
US$ 1,960.00
July 2016
50 pages
Hematology and Flow Cytometry--Strategic Assessments of Major Suppliers and Emerging Market Entrants
US$ 1,960.00
July 2016
30 pages
Infectious Diseases--Strategic Assessments of Major Suppliers and Emerging Market Entrants
US$ 1,960.00
July 2016
90 pages
2020 Global Cancer Diagnostics Market: Strategic Assessments of Major Suppliers and Emerging Market Entrants
US$ 2,500.00
January 2020
80 pages
